nRichDX
  • Applications
    • cfDNA
    • Total cell-free Nucleic Acid
    • Circulating Tumor Cells (Under Development)
    • Exosomes (Future Development)
    • Infectious disease (Future Development)
  • Platform
    • Overview
    • Reference Materials
  • Products
    • Revolution Semi-Manual System (IVD)
    • Revolution Semi-Automated Workflow (RUO)
  • Company
    • About nRichDX
    • News & Events
    • Executive Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Advisory Board
    • Careers
    • Contact
  • Extraction Service
  • Get A Quote

Reference Materials

AMP2022 PosterImageThumbnail

Higher Total RNA Yields and Sequenceable RNA is Attainable Using the nRichDX Revolution Sample Prep System Total Nucleic Acid Isolation Kit

 

Venue: Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo

Date: November 2022

This poster demonstrates the Revolution cell-free Total Nucleic Acid Isolation Kit's ability to extract circulating cell-free total nucleic acid (cfNA) including circulating free RNA (cfRNA) from plasma samples of up to 20 mL in a single extraction. High-performance Next Generation Sequencing (NGS) results from cfRNA were obtained as compared to two competing methods.

Colli-Pee Revolution System Compatability Poster AMP 2022_Thumbnail

Colli-Pee® UAS™ Combined withnRichDX Revolution System™, a Promising Urinary Cell-free DNA Collection, Preservation and Extraction Workflow

 

Venue: Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo

Date: November 2022

This poster demonstrates the compatibility of the Colli-Pee and UAS urine collection system from Novosanis with the nRichDX Revolution Sample Prep System for extraction of cfDNA from up to 20 mL of urine in a single extraction. cfDNA yield, purity, and other factors were compared with other sample prep methods.

HubSpot Video

Molecular Profiling of Urine for Prostate Cancer Diagnosis: Opportunities and Challenges (video)

 

Venue: Webinar

Date: September 2022

This joint webinar with nRichDX partner Novosanis covers current opportunities and challenges of urine as a sample type for molecular profiling of prostate cancer from Keynote Presenter, Dr. Simpa Salami, Assistant Professor of Urology and Co-Director of the University of Michigan's Liquid Biopsy Core Laboratory.

HubSpot Video

The Revolution Sample Prep System for Liquid Biopsy Applications (video)

 

Venue: Cancer Genomics Consortium (CGC) 2022 13th Annual Meeting

Date: August 2022

This video provides a brief introduction to the Revolution Sample Prep System from Nafiseh Jafari, PhD of nRichDX.

CGC 2022 cfRNA poster_thumbnail

Higher cfRNA Recovery and Precision from Large Urine Sample Volumes Using the nRichDX Revolution Sample Prep System

 

Venue: Cancer Genomics Consortium (CGC) 2022 13th Annual Meeting

Date: August 2022

This poster demonstrates the Revolution Sample Prep System's ability to extract circulating free total nucleic acid (cfNA) and circulating free RNA (cfRNA) from urine samples of up to 20 mL in a single extraction.

CGC 2022 cfDNA poster_thumbnail

Higher cfDNA Recovery and Precision from Large Urine Sample Volumes Using the nRichDX Revolution Sample Prep System

 

Venue: Cancer Genomics Consortium (CGC) 2022 13th Annual Meeting

Date: August 2022

This poster demonstrates the Revolution Sample Prep System's compatibility with the Novosanis® Colli-Pee® sample collection and stabilization system for recovery of cfDNA from urine samples of up to 20 mL in a single extraction.

Revolution System_Minion Sequencing_AMP 2021

MinION Nanopore Sequencing of cell-free DNA (cfDNA) and cell-free RNA (cfRNA) extracted from human plasma using nRichDX Revolution System

 

Venue: Association for Molecular Pathology (AMP) 2021 Annual Meeting

Date: November 2021

This poster demonstrates the Revolution Sample Prep System's compatibility with Oxford Nanopore Technologies MinION sequencing device for NGS sequencing of cfDNA and cfRNA.


Revolution System_Semi-Automated Workflow_epMotion 5073_AMP 2021

Semi-Automated High Yield cfDNA Extraction Using nRichDX Revolution Sample Prep System on Eppendorf epMotion for Liquid Biopsy Development

 

Venue: Association for Molecular Pathology (AMP) 2021 Annual Meeting

Date: November 2021

This poster describes the Semi-Automated Workflow of Revolution Sample Prep on the Eppendorf epMotion 5073 liquid handler.


nRichDX Revolution System_AMP2019

nRichDX Revolution Instrument and cfDNA isolation Kit for Extraction of cfDNA from Large Plasma and Urine Sample Volumes Improves Yield of Rare Targets

 

Venue: Association for Molecular Pathology (AMP) 2019 Annual Meeting

Date: November 2019

This poster introduces the Revolution Sample Prep System for extraction of cfDNA from plasma and urine samples as compared to a competing sample prep kit.


Revolution System_Dartmouth_AMP2019

Assessment of the nRichDX Revolution Instrument and Isolation kit for cell-free DNA extraction from liquid biopsy

 

Venue: Association for Molecular Pathology (AMP) 2019 Annual Meeting

Date: November 2019

This poster from the laboratory of Dr. Gregory Tsongalis evaluand ates the nRichDX Revolution Sample Prep System for extraction of cfDNA aand

nRichDX(r) logo footer

Contact Us

15339 Barranca Parkway
Irvine, CA 92618

info@nrichdx.com

techsupport@nrichdx.com

orders@nrichdx.com

+1 (949) 341-1980

(833) nRichDX; (833) 674-2439

Follow us

Linkedin Twitter Facebook
© 2019-2023 NRICHDX. ALL RIGHTS RESERVED.